At a glance
- Originator Biomedica Foscama
- Class Anti-ischaemics; Small molecules; Vitamins
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction
Most Recent Events
- 10 Oct 1997 Discontinued-Preclinical for Myocardial infarction in Italy (Unknown route)
- 30 May 1997 No-Development-Reported for Myocardial infarction in Italy (Unknown route)